Dennis Langer, Director at MYRIAD GENETICS INC (MYGN), sold 10,000 shares at $65.73 ($648K) on 2008-09-04, disclosed to the SEC on 2008-09-08.
Open-market sale of $648k MYGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.73 | 5,720 | $376K | 58.0% |
| 2 | $63.50 | 4,280 | $272K | 42.0% |
| Total | $64.78 avg | 10,000 | $648K | 100% |
| Filing → |
| MYGN | SELL | 2021-08-05 | $1.0M | — | Filing → |
| DRNA | SELL | 2018-08-17 | $613K | — | Filing → |
| MYGN | SELL | 2018-06-08 | $1.6M | — | Filing → |